U.S. flag

An official website of the United States government

NM_000297.4(PKD2):c.203dup (p.Ala69fs) AND Polycystic kidney disease 2

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Jan 24, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002289770.3

Allele description [Variation Report for NM_000297.4(PKD2):c.203dup (p.Ala69fs)]

NM_000297.4(PKD2):c.203dup (p.Ala69fs)

Genes:
LOC129992813:ATAC-STARR-seq lymphoblastoid silent region 15559 [Gene]
PKD2:polycystin 2, transient receptor potential cation channel [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
4q22.1
Genomic location:
Preferred name:
NM_000297.4(PKD2):c.203dup (p.Ala69fs)
HGVS:
  • NC_000004.12:g.88007936dup
  • NG_008604.1:g.5269dup
  • NM_000297.4:c.203dupMANE SELECT
  • NP_000288.1:p.Ala69fs
  • NC_000004.11:g.88929082_88929083insC
  • NC_000004.11:g.88929088dup
  • NM_000297.3:c.203dup
  • NM_000297.3:c.203dupC
  • NR_156488.2:n.302dup
Protein change:
A69fs
Links:
OMIM: 173910.0007; dbSNP: rs1187336837
NCBI 1000 Genomes Browser:
rs1187336837
Molecular consequence:
  • NM_000297.4:c.203dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NR_156488.2:n.302dup - non-coding transcript variant - [Sequence Ontology: SO:0001619]
Observations:
1

Condition(s)

Name:
Polycystic kidney disease 2 (PKD2)
Synonyms:
POLYCYSTIC KIDNEY DISEASE, ADULT, TYPE II; POLYCYSTIC KIDNEY DISEASE 2 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE
Identifiers:
MONDO: MONDO:0013131; MedGen: C2751306; OMIM: 613095

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000034729OMIM
no assertion criteria provided
Pathogenic
(Mar 1, 1999)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV002580810MGZ Medical Genetics Center
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jan 24, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

Germinal and somatic mutations in the PKD2 gene of renal cysts in autosomal dominant polycystic kidney disease.

Koptides M, Hadjimichael C, Koupepidou P, Pierides A, Constantinou Deltas C.

Hum Mol Genet. 1999 Mar;8(3):509-13.

PubMed [citation]
PMID:
9949210

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From OMIM, SCV000034729.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In 7 of 21 cysts from both kidneys of a patient with polycystic kidney disease (PKD2; 613095), Koptides et al. (1999) identified a C insertion within the inherited wildtype PKD2 allele. This C insertion was different from the one previously identified (693insC; 173910.0004) in this family as the germline mutation. The insertion occurred within a sequence of 6 consecutive cytosines (nucleotides 197-203), encoding amino acids 66-68. The authors were unable to determine exactly where the insertion of the cytosine occurred. The mutation was expected to create a translation frameshift, leading to the incorporation of 22 novel amino acids before reaching a stop codon. A polymorphism at nucleotide 83, which was occupied by either G or C, encoding either arginine or proline, enabled Koptides et al. (1999) to verify that the C insertion had occurred in the inherited wildtype allele.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From MGZ Medical Genetics Center, SCV002580810.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

Last Updated: May 7, 2024